Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2024 | May 07, 2024 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Amendment Flag | false | |
Document Quarterly Report | true | |
Document Transition Report | false | |
Document Period End Date | Mar. 31, 2024 | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2024 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 333-260902 | |
Entity Registrant Name | Bubblr, Inc. | |
Entity Central Index Key | 0001873722 | |
Entity Tax Identification Number | 86-2355916 | |
Entity Incorporation, State or Country Code | WY | |
Entity Address, Address Line One | 21 West 46th Street | |
Entity Address, City or Town | New York | |
Entity Address, State or Province | NY | |
Entity Address, Postal Zip Code | 10036 | |
City Area Code | (646) | |
Local Phone Number | 814 7184 | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | true | |
Elected Not To Use the Extended Transition Period | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 159,690,447 |
Consolidated Balance Sheets (Un
Consolidated Balance Sheets (Unaudited) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Current Assets: | ||
Cash | $ 951 | $ 7,668 |
Other receivables | 88,937 | 87,503 |
Total current assets | 89,888 | 95,171 |
Non-current Assets: | ||
Property and equipment, net | 2,349 | 31,302 |
Intangible assets, net | 1,409,681 | 1,456,628 |
Total non-current assets | 1,412,030 | 1,487,930 |
TOTAL ASSETS | 1,501,918 | 1,583,101 |
Current Liabilities: | ||
Accounts payable | 398,365 | 373,606 |
Accrued liabilities | 1,106,074 | 943,007 |
Total current liabilities | 1,768,409 | 1,487,471 |
Non-current liabilities: | ||
Warrant derivative liability | 40,367 | 39,116 |
Total non-current liabilities | 588,708 | 591,755 |
Total Liabilities | 2,357,117 | 2,079,226 |
Stockholders’ Equity (Deficit) | ||
Series C Convertible Preferred Stock, $0.001 par value, 2,000 authorized, 903 shares issued and outstanding | 1 | 1 |
Common stock, $0.01 par value, 3,000,000,000 shares authorized; 159,690,447 shares issued and outstanding at March 31, 2024, and December 31, 2023 | 1,596,904 | 1,596,904 |
Additional paid-in capital | 13,277,905 | 13,168,915 |
Accumulated deficit | (16,095,315) | (15,612,775) |
Accumulated other comprehensive income | 365,306 | 350,830 |
Total Stockholders’ Equity (Deficit) | (855,199) | (496,125) |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) | 1,501,918 | 1,583,101 |
Nonrelated Party [Member] | ||
Current Liabilities: | ||
Loan payable | 12,611 | |
Non-current liabilities: | ||
Loan payable - related party, non-current | 0 | |
Related Party [Member] | ||
Current Liabilities: | ||
Loan payable | 263,970 | 158,247 |
Non-current liabilities: | ||
Loan payable - related party, non-current | $ 548,341 | $ 552,639 |
Consolidated Balance Sheets (_2
Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 04, 2023 |
Preferred stock, par value | $ 0.001 | ||
Preferred stock, shares authorized | 25,000,000 | ||
Common stock, par value | $ 0.01 | $ 0.01 | |
Common stock, shares authorized | 3,000,000,000 | 3,000,000,000 | |
Common stock, shares issued | 159,690,447 | 159,690,447 | |
Common stock, shares outstanding | 159,690,447 | 159,690,447 | |
Series C Preferred Stock [Member] | |||
Preferred stock, par value | $ 0.001 | $ 0.001 | $ 1,200 |
Preferred stock, shares authorized | 2,000 | 2,000 | 2,000 |
Preferred stock, shares issued | 903 | 903 | |
Preferred stock, shares outstanding | 903 | 903 |
Consolidated Statement of Opera
Consolidated Statement of Operations and Comprehensive Loss (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Revenue | ||
Sales | $ 1,504 | |
Cost of sales | 622 | |
Gross profit | 882 | |
Operating Expenses | ||
General and administrative | 310,068 | 16,289 |
Professional fees | 8,028 | (225,570) |
Sales and marketing | 18,173 | 312,463 |
Amortization and depreciation | 53,991 | 59,627 |
Research and development | 47,865 | 39,152 |
Total operating expense | 438,125 | 201,961 |
Operating loss | (437,243) | (201,961) |
Other income (expense) | ||
Other income | 1,478 | 98 |
Interest expense | (3,592) | (1,129) |
Disposal of fixed assets | (9,355) | |
Gain (loss) on change in fair value of warrant derivative liability | (1,251) | (72,519) |
Foreign currency transaction (loss) gain | (10,904) | 21,175 |
Total other income (expense) | (23,624) | (52,375) |
Net loss before income tax | (460,867) | (254,336) |
Provision for income tax | ||
Net loss after income tax | (460,867) | (254,336) |
Other comprehensive income (loss) | ||
Foreign currency translation gain (loss) | 14,476 | (19,142) |
Total other comprehensive income (loss) | 14,476 | (19,142) |
Net comprehensive loss | $ (446,391) | $ (273,478) |
Net loss per common share, basic | $ 0 | $ 0 |
Net loss per common share, diluted | $ 0 | $ 0 |
Weighted average number of common shares outstanding, basic | 159,690,447 | 154,904,171 |
Weighted average number of common shares outstanding, diluted | 159,690,447 | 154,904,171 |
Consolidated Statement of Chang
Consolidated Statement of Changes in Stockholders' Deficit (Unaudited) - USD ($) | Preferred Stock [Member] Series C Preferred Stock [Member] | Common Stock [Member] | Additional Paid-in Capital [Member] | Retained Earnings [Member] | AOCI Attributable to Parent [Member] | Series C Preferred Stock [Member] | Total |
Balance at Dec. 31, 2022 | $ 1 | $ 1,543,093 | $ 11,006,607 | $ (12,875,437) | $ 412,013 | $ 86,277 | |
Balance, shares at Dec. 31, 2022 | 903 | 154,309,318 | |||||
Issuance of common shares for Services - Consulting | $ 14,558 | 270,780 | 285,338 | ||||
Issuance of common shares for Services - Consulting, shares | 1,455,784 | ||||||
Forfeit of restricted stock units | (659,052) | (659,052) | |||||
Issuance of common shares for Series C Preferred Shares Dividend | $ 1,837 | 20,296 | 22,133 | ||||
Issuance of common shares for series C Preferred Shares Dividend, shares | 183,676 | ||||||
Dividend Series C Preferred Shares | (21,672) | (21,672) | |||||
Net Loss | (254,336) | (254,336) | |||||
Other comprehensive income | (19,142) | (19,142) | |||||
Balance at Mar. 31, 2023 | $ 1 | $ 1,559,488 | 10,638,631 | (13,151,445) | 392,871 | (560,454) | |
Balance, shares at Mar. 31, 2023 | 903 | 155,948,778 | |||||
Balance at Dec. 31, 2023 | $ 1 | $ 1,596,904 | 13,168,915 | (15,612,775) | 350,830 | (496,125) | |
Balance, shares at Dec. 31, 2023 | 903 | 159,690,447 | |||||
Issuance of common shares for Series C Preferred Shares Dividend | $ 43,805 | ||||||
Dividend Series C Preferred Shares | (21,673) | (21,673) | |||||
Net Loss | (460,867) | (460,867) | |||||
Other comprehensive income | 14,476 | 14,476 | |||||
Vesting of Share Options | 108,990 | 108,990 | |||||
Balance at Mar. 31, 2024 | $ 1 | $ 1,596,904 | $ 13,277,905 | $ (16,095,315) | $ 365,306 | $ (855,199) | |
Balance, shares at Mar. 31, 2024 | 903 | 159,690,447 |
Consolidated Statement of Cashf
Consolidated Statement of Cashflows (Unaudited) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Cash Flows from Operating Activities: | ||
Net loss | $ (460,867) | $ (254,336) |
Net loss to net cash used in operating activities: | ||
Stock-based compensation | 285,338 | |
Forfeit of restricted stock units | (659,052) | |
Vesting of stock-based compensation | 108,990 | |
Change in fair value of warrant derivative liability | 1,251 | 72,519 |
Disposal of fixed assets | 9,355 | |
Amortization of intangible asset | 51,489 | 56,521 |
Depreciation | 2,502 | 3,106 |
Changes in operating assets and liabilities: | ||
(Increase) decrease in other receivables | (2,121) | 3,778 |
Increase in accounts payable | 25,674 | 336,901 |
Increase in accrued liabilities | 145,563 | (3,156) |
Net cash used in operating activities | (118,164) | (158,381) |
Cash flows from investing activities | ||
Purchase of intangible assets | (15,566) | (11,138) |
Proceeds on the sale of fixed assets | 16,960 | |
Net cash used in investing activities | 1,394 | (11,138) |
Cash flows from financing activities | ||
Repayment of loans payable | (12,611) | (2,430) |
Repayment of loans payable - related party | (18,228) | |
Proceeds from loans payable - related party | 105,076 | 223,777 |
Net cash provided by financing activities | 92,465 | 203,119 |
Effects of exchange rate changes on cash | 17,588 | (31,018) |
Net Change in Cash | (6,717) | 2,582 |
Cash - Beginning of Period | 7,668 | 32,533 |
Cash - End of Period | 951 | 35,115 |
Supplemental information: | ||
Cash paid for interest | 301 | 4,774 |
Cash paid for taxes |
ORGANIZATION, BUSINESS AND LIQU
ORGANIZATION, BUSINESS AND LIQUIDITY | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
ORGANIZATION, BUSINESS AND LIQUIDITY | NOTE 1 - ORGANIZATION, BUSINESS AND LIQUIDITY Organization and Operations On March 26, 2020, Bubblr Holdings Ltd. (a UK company formed on February 18, 2016) merged into U.S. Wireless Online, Inc. (“UWRL”), a Wyoming corporation formed on October 22, 2019 100 Bubblr, Inc. is an application software company that is currently developing its disruptive Ethical Web platform. This WEB.Ɛ platform will provide a holistic view of progress in developing digital products, services, and teams — designed to inform our ability to use our in-house code and that of our partners, lead advances in development criteria, and respond quickly to shifts in trends and applications. Going Concern Matters The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”), which contemplates the Company’s continuation as a going concern. The Company incurred a net comprehensive loss of $ 446,391 16,095,315 1,678,521 Management intends to raise additional operating funds through equity and/or debt offerings. However, there can be no assurance management will be successful in its endeavors. There are no assurances that the Company will be able to either (1) achieve a level of revenues adequate to generate sufficient cash flow from operations; or (2) obtain additional financing through either private placement, public offerings, and/or bank financing necessary to support its working capital requirements. To the extent that funds generated from operations and any private placements, public offerings, and/or bank financing are insufficient, the Company will have to raise additional working capital. No assurance can be given that additional financing will be available, or if available, will be on terms acceptable to the Company. If adequate working capital is not available to the Company, it may be required to curtail or cease its operations. Due to uncertainties related to these matters, there exists substantial doubt about the ability of the Company to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments related to the recoverability or classification of asset-carrying amounts or the amounts and classification of liabilities that may result should the Company be unable to continue as a going concern. |
SIGNIFICANT ACCOUNTING POLICIES
SIGNIFICANT ACCOUNTING POLICIES | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31. Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments adjusted to fair market value on reporting dates. At March 31, 2024 and December 31, 2023 the warrant liabilities balances were $ 40,367 39,116 Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation–Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the financial statements based on the fair values of the stock awards on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period ). Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2024, and 2023, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236 Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the exchange rates on the balance sheet date, and local currency revenues and expenses are translated at weighted average exchange rates during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2199 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2447 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $ 5,210 19,142 Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount believed more likely than not to be realized. As of March 31, 2024, and December 31, 2023, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% of any “taxable diverted profit.”. The DPT has had an effect since April 1, 2015, and may apply in circumstances including (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements. Reclassifications Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented. |
OTHER RECEIVABLES
OTHER RECEIVABLES | 3 Months Ended |
Mar. 31, 2024 | |
Other Receivables | |
OTHER RECEIVABLES | NOTE 3 – OTHER RECEIVABLES As of March 31, 2024, and December 31, 2023, accounts receivable consisted of the following: SCHEDULE OF OTHER RECEIVABLES March 31, December 31, 2024 2023 Deposit $ 200 $ 200 UK R&D credit 79,582 80,205 UK VAT receivable 9,155 7,098 Total other receivables $ 88,937 $ 87,503 |
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT | 3 Months Ended |
Mar. 31, 2024 | |
Property, Plant and Equipment [Abstract] | |
PROPERTY AND EQUIPMENT | NOTE 4 - PROPERTY AND EQUIPMENT As of March 31, 2024, and December 31, 2023, property and equipment consisted of the following: SCHEDULE OF PROPERTY PLANT AND EQUIPMENT Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2023 $ 53,470 $ 29,646 $ - $ 83,116 Additions - - - - Disposals (53,054 ) (3,502 ) - (56,556 ) Effects of currency translation (416 ) (231 ) - (647 ) At March 31, 2024 - 25,913 - 25,913 Less accumulated depreciation At December 31, 2023 $ 25,997 $ 25,817 $ - $ 51,814 Depreciation expense 1,053 1,449 - 2,502 Disposals (26,847 ) (3,502 ) - (30,349 ) Effects of currency translation (203 ) (200 ) - (403 ) At March 31, 2024 - 23,564 - 23,564 Net book value At March 31, 2024 - 2,349 - 2,349 At December 31, 2023 $ 27,473 $ 3,829 $ - $ 31,302 During the three months ended March 31, 2024, the Company recorded depreciation expenses of $ 2,502 9,317 |
INTANGIBLE ASSETS
INTANGIBLE ASSETS | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
INTANGIBLE ASSETS | NOTE 5 - INTANGIBLE ASSETS A Patent on the Internet-Search Mechanism (“IBSM”) has been granted in the United States, South Africa, New Zealand, Canada, and Australia. The patent is pending in the European Union, and the United Kingdom. Patents on Contextual Enveloping of Dynamic Hypertext Links and Real-Time Data Processing are pending in the United States Patents are reported at cost, less accumulated amortization, and accumulated impairment loss. Costs include expenditure that is directly attributable to the acquisition of the asset. Once a patent provides economic benefit to the Company, amortization is provided on a straight-line basis on all patents over their expected useful lives of 20 Intellectual Property Intellectual Property capitalizes the Company’s qualifying internal research and developments costs . 7 Trademarks The Company has the following trademarks. Mark Category Proprietor Country Class(es) Status Reg. Date. File No. CITIZENS JOURNALIST Words Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206382.EM.01 CITIZENS JOURNALIST Word Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206382.GB.01 CITIZENS JOURNALIST Words Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206382.GB.02 CITIZENS JOURNALIST Word Bubblr Limited United States 9 38 41 42 REGD-DEC USE 08-Feb-2022 206382.US.01 Words and Color Device Bubblr Limited European Union 9 38 REGISTERED 16-Nov-2019 206383.EM.01 Series of Logos Bubblr Limited United Kingdom 9 38 REGISTERED 05-Jul-2019 206383.GB.01 Words and Color Device Bubblr Limited United Kingdom 9 38 REGISTERED 16-Nov-2019 206383.GB.02 Words and Device Bubblr Limited United States 9 38 41 42 ACCEPTED 206383.US.01 BAU NOT OK/BAU Not OK Series of Marks Bubblr Limited United Kingdom 9 38 REGISTERED 11-Oct-2019 208674.GB.01 NEWZMINE/NewzMine Series of Marks Bubblr Limited United Kingdom 9 38 42 REGISTERED 25-Dec-2020 227753.GB.01 The Company capitalizes trademark costs where the likelihood of acceptance is expected. Each trademark has been determined to have an infinite useful life and is assessed each reporting period for impairment. If there has been a reduction in the value of the trademark or if the trademark is not successfully registered, the assets will be impaired and charged to expense in the period of impairment. As of March 31, 2024, and December 31, 2023, trademarks consisted of the following: SCHEDULE OF TRADEMARKS March 31, December 31, 2024 2023 Trademarks: NewzMine TM $ 13,421 $ 12,994 Citizens Journalist™ 25,367 25,367 Effects of currency translation (2,088 ) (1,804 ) $ 36,700 $ 36,558 As of March 31, 2024, and December 31, 2023, intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total Cost At December 31, 2023 $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Cost, beginning $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Additions 15,139 427 - - 15,566 Effects of currency translation (1,718 ) (285 ) (24,180 ) - (26,183 ) At March 31, 2024 $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Cost, ending $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Less accumulated amortization At December 31, 2023 $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Less accumulated amortization, beginning $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Amortization expense 1,630 - 49,287 572 51,489 Effects of currency translation (70 ) - (15,089 ) - (15,159 ) At March 31, 2024 $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Less accumulated amortization, ending $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Net book value At March 31, 2024 $ 224,246 $ 36,700 $ 1,110,426 $ 38,309 $ 1,409,681 At December 31, 2023 $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628 During the three months ended March 31, 2024, the Company purchased $ 15,566 51,489 No |
ACCRUED LIABILITIES
ACCRUED LIABILITIES | 3 Months Ended |
Mar. 31, 2024 | |
Payables and Accruals [Abstract] | |
ACCRUED LIABILITIES | NOTE 6 – ACCRUED LIABILITIES As of March 31, 2024, and December 31, 2023, accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES March 31, December 31, 2024 2023 Director fees $ 120,000 $ 90,000 Dividends payable 86,688 65,016 Other accruals 49,892 76,945 Settlement payable 166,986 166,986 Wages and salaries 682,508 544,060 Total Accrued liabilities $ 1,106,074 $ 943,007 |
LOAN PAYABLE
LOAN PAYABLE | 3 Months Ended |
Mar. 31, 2024 | |
Debt Disclosure [Abstract] | |
LOAN PAYABLE | NOTE 7 – LOAN PAYABLE In November 2019, the Company purchased a vehicle under a capital finance arrangement. The term of this loan was 5 6.90 0 11,987 0 12,611 During the three months ended March 31, 2024, and 2022, the Company made $ 1,691 2,430 The vehicle was sold in February 2024. |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 3 Months Ended |
Mar. 31, 2024 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 8 - RELATED PARTY TRANSACTIONS Loans from Related Parties The Company has loans from our founder, Stephen Morris, with a balance of $ 1,316,435 678,549 Loan 1 - Stephen Morris, Founder, CTO and Chair. On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment. In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD, the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date On September 6, 2022, the Company entered into a second amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to add $ 60,000 52,088 On December 20, 2022, the Company entered into a third amendment (the “Amendment”) with Bubblr Limited and Mr. Morris to reduce the outstanding principal amount of the loan by $ 71,540 59,543 71,540 59,543 On December 27, 2023, Stephen Morris converted $ 821,431.87 2,489,186 0.33 At March 31, 2024, and December 31, 2023, Loan 1 payable obligations included in current liabilities were $ 229,575 125,910 Loan 2 - Stephen Morris, Founder, CTO and Chair. On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for $ 501,049 434,060 no At March 31, 2024, and December 31, 2023, Loan 2 payable obligations included in current liabilities were $ 552,639 548,341 Activity on Loan 1 and Loan 2 arrive at March 31, 2024, and December 31, 2023, balances is as follows: SCHEDULE OF RELATED PARTY TRANSACTION SHARE HOLDERS LOANS Three Months Ended Year Ended 2024 2023 Beginning balance loan 1 current $ 125,910 374,018 Effects of currency translation (980 ) 62,356 Additions 104,930 510,968 Loan resolution agreement – Stephen Morris - (821,432 ) Ending balance – loan 1 current $ 229,575 $ 125,910 Beginning balance loan 2 non-current $ 552,639 $ 525,291 Effects of currency translation (4,298 ) 27,348 Ending balance loan 2 non-current $ 548,341 552,639 Ending balance loan 1 and loan 2 current and non-current $ 777,916 $ 678,549 Related Party Loan – Professor Paul Morrissey, Director. On September 8, 2022, the Company entered into a new loan agreement (the “Loan Agreement”) with Professor Paul Morrissey for $ 32,337 25,401 6,954 5,700 2.85 34,395 27,229 32,337 25,401 |
WARRANT LIABILITY
WARRANT LIABILITY | 3 Months Ended |
Mar. 31, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
WARRANT LIABILITY | NOTE 9 - WARRANT LIABILITY The Company analyzed the warrants issued in connection with the Series C Convertible Preferred Stock (see Note 10) for derivative accounting consideration under ASC 815, Derivatives and Hedging, and determined that the instruments should be classified as a liability due to reset provisions and variability in exercise price resulting in there being no fixed value or explicit limit to the number of shares to be delivered upon exercise. ASC 815 requires us to assess the fair market value of the derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our warrant liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities and used the Black Scholes pricing model to calculate the fair value as of March 31, 2024. The Black Scholes model requires three basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each warrant is estimated using the Black-Scholes valuation model. For the period ended March 31, 2024, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows : SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS Three Months Ended March 31, 2024 Expected term 1.59 2.50 Expected average volatility 177 220 % Expected dividend yield 8.33 % Risk-free interest rate 1.50 5.46 % The following table summarizes the changes in the warrant liabilities during the three months ended March 31, 2024, and year ended December 31, 2023: SUMMARY OF CHANGES IN WARRANT LIABILITIES Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability December 31, 2022 $ 198,479 Addition of new warrants - Change in fair value of warrant liability (159,363 ) Warrant liability as of December 31, 2023 $ 39,116 Addition of new warrants $ - Change in fair value of warrant liability 1,251 Warrant liability as of March 31, 2024 $ 40,367 |
STOCKHOLDERS_ EQUITY
STOCKHOLDERS’ EQUITY | 3 Months Ended |
Mar. 31, 2024 | |
Equity [Abstract] | |
STOCKHOLDERS’ EQUITY | NOTE 10 - STOCKHOLDERS’ EQUITY Preferred Stock The Company has authorized 25,000,000 0.001 Series C Convertible Preferred Stock On March 4, 2023, the Company filed a Certificate of Designation with the Wyoming Secretary of State, which established 2,000 1,200 The Company has the right to redeem the Series C Convertible Preferred Stock in accordance with the following schedule: ● The Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and ● The Company shall pay an 8 The Series C Convertible Preferred Stock will vote together with the common stock on an as-converted basis subject to the Beneficial Ownership Limitations (as set forth in the Certificate of Designation). Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $ 1,200 0.3202 On March 4, 2022, the Company entered into a Securities Purchase Agreement (the “GHS Securities Purchase Agreement”) with GHS Investments, LLC (“GHS”), whereby GHS agreed to purchase, in tranches, up to $ 700,000 700 On March 4, 2022, the Company issued to GHS the first tranche of 300 35 941,599 75 GHS delivered gross proceeds of $ 266,000 On March 9, 2022, the Company entered a Securities Purchase Agreement with Proactive Capital Partners LP (“Proactive”), whereby Proactive agreed to purchase 160 The Company agreed to issue Proactive commitment shares of 8 472,205 75 On March 9, 2022, the Company issued 168 290,000 On April 24, 2022, the Company issued the second tranche of 200 562,149 184,000 On May 25, 2022, the Company issued the third tranche of 100 92,000 On September 24, 2022, the Company issued the fourth tranche of 100 281,074 92,000 On September 7, 2022, our wholly owned subsidiary, Bubblr Limited, entered into a new loan agreement (the “Loan Agreement”) with Mr. Morris for £ 434,060 550,468 200,000 345,220 281,000 64,220 71,703 As a result of the above transactions, the Company received total net proceeds of $ 789,000 721,275 28,043 95,768 As at March 31, 2024 and December 31, 2023, the Company had 903 Common Stock The Company has authorized 3,000,000,000 0.01 During the three months ended March 31, 2023, the Company issued the following unregistered securities: ● 625,000 100,000 ● 500,000 65,000 ● 311,159 43,805 ● 1,455,784 285,338 During the three months ended March 31, 2024, the Company did not issue unregistered securities. As at March 31, 2024, and December 31, 2023, the Company had 159,690,447 The above securities were issued in reliance on the exemption from registration provided by Section 4.(a)(2) of the Securities Act of 1933, as amended, and/or in reliance on the exception from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended. Warrants The Company identified conversion features embedded within warrants issued during the three months ended March 31, 2023. The Company has determined that the conversion feature of the Warrants represents an embedded derivative since the conversion price includes a reset provision which could cause adjustments in redemption value and the number of shares issued upon exercise (see Note 9 - Warrant Liability). A summary of activity during the three-month period ended March 31, 2024, follows: SUMMARY OF WARRANTS ACTIVITY Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2023 2,538,101 $ 0.32 4.27 Granted - - - Exercised - - - Forfeited/canceled - - - Outstanding, March 31, 2024 2,538,101 $ 0.32 3.52 Exercisable Warrants, March 31, 2024 2,538,101 $ 0.32 3.52 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2024: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 941,599 3.43 $ 0.34 941,599 $ 0.34 472,205 3.44 0.34 472,205 0.34 562,149 3.57 0.35 562,149 0.35 281,074 3.65 0.22 281,074 0.22 281,074 3.74 0.22 281,074 0.22 2,538,101 3.52 $ 0.32 2,538,101 $ 0.32 As at March 31, 2024, the intrinsic value of the warrants is $ 0 2022 Equity Incentive Plan On April 1, 2023, the Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The Board of Directors determine the terms of the stock option grants that are consistent with our 2022 Equity Incentive Plan. Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years. The following table summarizes the stock options activity for the three months ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY Number of Shares Weighted-Average Exercise Price (per share) Outstanding as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Exercised - - Forfeited or expired - - Outstanding at March 31, 2023 14,400,000 $ 0.1560 Exercisable at March 31, 2024 10,788,000 Weighted-average fair value of options granted in the period $ 0.1560 The total intrinsic value of options on March 31, 2023, is zero because the closing stock price was below the weighted average exercise value. The weighted average fair value of stock options granted is based on the Black-Scholes option pricing model using the following weighted average assumptions. SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS Three Month March 31, 2024 Expected life in years 9.01 Risk-free interest rate 4.20 % Annual forfeiture rate 0 % Volatility 221 % Expected dividend yield 0 % The following table summarizes certain information regarding the Company’s non-vested shares as of the three-month period ended March 31, 2024: SCHEDULE OF NON-VESTED SHARES Number of Shares Weighted-Average Non-vested as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Forfeited or expired - - Vested (10,788,000 ) 0.1560 Non-vested as of March 31, 2024 3,612,000 $ 0.1560 The following table summarizes the stock options exercisable for the three-month period ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE Options Options Outstanding Exercisable Number of shares 14,400,000 10,788,000 Weighted-average contractual life in years 9.01 9.01 Weighted-average exercise price $ 0.1560 $ 0.1614 Intrinsic value $ 0.00 $ 0.00 As of March 31, 2024, the Company recognized $ 108,990 517,783 |
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES | 3 Months Ended |
Mar. 31, 2024 | |
Commitments and Contingencies Disclosure [Abstract] | |
COMMITMENTS AND CONTINGENCIES | NOTE 11 - COMMITMENTS AND CONTINGENCIES Lease The Company rents virtual space month-to-month at 21 West 46th St, New York, NY 10036 . 200 his lease is exempt from ASC 842 lease accounting due to its short term. Investor Relations On February 14, 2023, the Company entered a Consulting Agreement with Beyond Media SEZC. The agreement is for twelve months. Beyond Media will receive $ 7,000 1,000,000 180,000 On June 15, 2023, the Company entered a Consulting Agreement with Launchpad LLC. The agreement is for six months. Launchpad LLC will receive $ 3,000 Steven Saunders, Former Chief Commercial Officer, and Director On January 31, 2023, the Company entered Separation Agreements with Steven Saunders. He is no longer an officer or director of our Company, and all prior agreements are terminated. To satisfy all amounts due, Mr. Saunders and the Company agreed to a settlement totaling $ 116,000 79,250 Rik Willard, Former Chief Executive Officer, and Director On January 31, 2023, the Company entered into Separation Agreements with Rik Willard, our then-Chief Executive Officer. Mr. Willard is no longer an officer or director of our Company, and all prior agreements are terminated in their entirety. To satisfy all amounts due, Mr. Willard and the Company agreed to a settlement total sum of $ 112,418 86,811 Stephen Morris, Founder, Chief Technical Officer, and Director On April 1, 2023, the Company entered into an Amended Employment Agreement with Stephen Morris, Founder, Chief Technical Officer, and Chair. The Company will compensate Mr. Morris with $ 450,000 60 180,000 5,000,000 On April 1, 2023, the Company agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share (628,320) under the 2022 Incentive Plan Mr. Morris completed two years and three months of service. On December 31, 2023, the Company entered into a Second Amended Employment Agreement with Stephen Morris to reduce his base pay from $ 450,000 90,000 270,000 David Chetwood, Chief Financial Officer, and Director On April 1, 2023, the Company entered into an Amended Employment Agreement, effective February 10, 2023, with David Chetwood, Chief Financial Officer, and Director. The Company will compensate Mr. Chetwood with a base pay of $ 450,000 60 180,000 5,000,000 On May 12, 2023, the Company agreed to grant Mr. Chetwood an option to purchase 3,360,000 shares of common stock at $0.1625 per share ($546,000), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years 1,092,000 On December 31, 2023, the Company entered into a Second Amended Employment Agreement with David Chetwood to reduce his base pay from $ 450,000 180,000 236,200 Timothy Burks, Chief Executive Officer, and Director On April 1, 2023, the Company entered into an employment agreement with Timothy Burks, Chief Executive Officer, and Director. The Company will compensate Mr. Burks $600,000 per annum base pay with payments reduced by 60% to $240,000 per annum until the Company has secured $5,000,000 in debt or equity financing. On July 1, 2023, the Company agreed to grant Mr. Burks an option to purchase 4,800,000 shares of common stock at $0.1353 per share ($649,440), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years , under the 2022 Incentive Plan. As of March 31, 2024, there were 1,800,000 non-vested share options, which we will recognize over the next 15 months. On December 31, 2023, the Company entered into an Amended Employment Agreement with Timothy Burks to reduce his base pay from $ 600,000 240,000 270,000 Paul Morrissey, Director On April 6, 2023, the Company entered into a Non-executive Director Agreement with Paul Morrissey. The Company will compensate Mr. Morrissey $300,000 per annum directors fee, with payments reduced by 60% to $120,000 per annum until the Company has secured $5,000,000 in debt or equity financing. On July 6, 2023, the Company agreed to grant Mr. Morrissey an option to purchase 1,920,000 shares of common stock at $0.1353 per share ($259,776), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years 720,000 On December 31, 2023, the Company entered into an Amended Non-Executive Director Agreement with Morrissey to reduce his director fee from $ 300,000 120,000 270,000 |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 3 Months Ended |
Mar. 31, 2024 | |
Subsequent Events | |
SUBSEQUENT EVENTS | NOTE 12 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through May 7, 2024 when the financial statements were available to be issued. The Company has concluded no subsequent events have occurred that require disclosure. |
SIGNIFICANT ACCOUNTING POLICI_2
SIGNIFICANT ACCOUNTING POLICIES (Policies) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated interim financial statements have been prepared in accordance with GAAP. The Company’s fiscal year-end is December 31. |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries: Bubblr Holdings Ltd., Bubblr Ltd., and Bubblr CLN Ltd. All significant inter-company balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Some of these judgments can be subjective and complex, and, consequently, actual results may differ from these estimates. |
Convertible Financial Instruments | Convertible Financial Instruments The Company bifurcates conversion options from their host instruments and accounts for them as free-standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur, and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP. |
Fair Value of Financial Instruments | Fair Value of Financial Instruments The Company accounts for financial instruments in accordance with ASC 820, “Fair Value Measurements and Disclosures.” ASC 820 establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy under ASC 820 are described below: Level 1 – Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities. Level 2 – Quoted prices in non-active markets or in active markets for similar assets or liabilities, observable inputs other than quoted prices, and inputs that are not directly observable but are corroborated by observable market data. Level 3 – Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable. The carrying value of the Company’s current assets and liabilities are deemed to be their fair value due to the short-term maturity and realization. During the year ended December 31, 2022, the Company acquired warrant derivative liabilities, which are Level 3 financial instruments adjusted to fair market value on reporting dates. At March 31, 2024 and December 31, 2023 the warrant liabilities balances were $ 40,367 39,116 |
Stock Based Compensation | Stock Based Compensation The Company accounts for stock-based compensation in accordance with ASC Topic 718, “Compensation–Stock Compensation,” which prescribes accounting and reporting standards for all share-based payment transactions in which employee and non-employee services are acquired. Share-based payments to employees and non-employees, including grants of stock options, are recognized as compensation expenses in the financial statements based on the fair values of the stock awards on the grant date. That expense is recognized over the period required to provide services in exchange for the award, known as the requisite service period (usually the vesting period ). |
Common Stock Purchase Warrants and Derivative Financial Instruments | Common Stock Purchase Warrants and Derivative Financial Instruments Common stock purchase warrants and other derivative financial instruments are classified as equity if the contracts (1) require physical settlement or net-share settlement or (2) give the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). Contracts which (1) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (2) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement), or (3) that contain reset provisions that do not qualify for the scope exception are classified as liabilities. The Company assesses the classification of its common stock purchase warrants and other derivatives at each reporting date to determine whether a change in classification between equity and liabilities is required. |
Basic and Diluted Net Loss per Common Share | Basic and Diluted Net Loss per Common Share Pursuant to ASC 260, “Earnings Per Share,” basic net income and net loss per share are computed by dividing the net income and net loss by the weighted average number of common shares outstanding. Diluted net income and net loss per share is the same as basic net income and net loss per share when their inclusion would have an anti-dilutive effect due to our continuing net losses. For the three months ended March 31, 2024, and 2023, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236 |
Foreign Currency Translations | Foreign Currency Translations The functional currency of the Company’s international subsidiaries is generally their local currency of Great British Pounds (GBP). Local currency assets and liabilities are translated at the exchange rates on the balance sheet date, and local currency revenues and expenses are translated at weighted average exchange rates during the period. Equity accounts are translated at historical rates. The resulting translation adjustments are recorded directly into accumulated other comprehensive income. SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2199 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2447 Aggregate transaction gains or losses, including gains or losses related to foreign-denominated cash and cash equivalents and the re-measurement of certain inter-company balances, are included in the statement of operations as other income and expense. Gains on foreign exchange transactions totaling $ 5,210 19,142 |
Income Taxes | Income Taxes The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes.” The asset and liability method provides that deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities and for operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred tax assets to the amount believed more likely than not to be realized. As of March 31, 2024, and December 31, 2023, the Company did not have any amounts recorded pertaining to uncertain tax positions. UK Taxes We do not consider ourselves to be engaged in a trade or business in the UK and, as such, do not expect to be subject to UK corporate income taxation. We have subsidiaries based in the UK that are subject to the tax laws of that country. Under current law, those subsidiaries are taxed at the applicable corporate income tax rates. Should any UK subsidiaries be deemed to undertake business activities in the US, they would be subject to US corporate income tax in respect of their US activities only. Relief would then be available against the UK tax liabilities in respect of the overseas taxes arising from US activities. At present, this is not applicable as our UK subsidiaries only undertake activities in the UK. Our UK subsidiaries file separate UK income tax returns. UK Tax Risk Companies that are incorporated outside the UK may become subject to UK taxes in a number of circumstances, including circumstances in which (1) they are deemed resident in the UK for tax purposes by reason of their central management and control being exercised from the UK or (2) they are treated as carrying on a trade, investing or carrying on any other business activity in the UK, whether or not through a UK Permanent Establishment (“PE”). In addition, the Finance Act 2015 introduced a new tax known as the diverted profits tax (“DPT”), which is charged at 25% of any “taxable diverted profit.”. The DPT has had an effect since April 1, 2015, and may apply in circumstances including (1) where arrangements are designed to ensure that a non-UK resident company does not carry on a trade in the UK through a PE; and (2) where a tax reduction is obtained through the involvement of entities or transactions lacking economic substance. We intend to operate in such a manner that none of our companies should be subject to the UK DPT and that none of our companies (other than those companies incorporated in the UK) should: (1) be treated as resident in the UK for tax purposes; (2) carry on a trade, invest or carry on any other business activity in the UK (whether or not through a UK PE). However, this result is based on certain legal and factual determinations, and since the scope and the basis upon which the DPT will be applied by HM Revenue & Customs (“HMRC”) in the UK remains uncertain and since applicable law and regulations do not conclusively define the activities that constitute conducting a trade, investment or business activity in the UK (whether or not through a UK PE), and since we cannot exclude the possibility that there will be a change in law that adversely affects the analysis, HMRC might successfully assert a contrary position. The terms of an income tax treaty between the UK and the home country of the relevant Bubblr subsidiary, if any, could contain additional protections against UK tax. Any arrangements between UK-resident entities of Bubblr and other entities of Bubblr are subject to the UK transfer pricing regime. Consequently, if any agreement between a UK resident entity of Bubblr and any other Bubblr entity (whether that entity is resident in or outside of the UK) is found not to be on arm’s length terms and, as a result, a UK tax advantage is being obtained, an adjustment will be required to compute UK taxable profits as if such an agreement were on arm’s length terms. Any transfer pricing adjustment could adversely impact the tax charge incurred by the relevant UK resident entities of Bubblr. |
Recent Accounting Pronouncements | Recent Accounting Pronouncements The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial statements. |
Reclassifications | Reclassifications Certain accounts have been reclassified in prior periods to conform to current period presentation. Compensation expense that was previously reported separately has been combined with general and administrative expenses in the Consolidated Statements of Operations and Comprehensive Loss for all periods presented. |
SIGNIFICANT ACCOUNTING POLICI_3
SIGNIFICANT ACCOUNTING POLICIES (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Accounting Policies [Abstract] | |
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE | For the three months ended March 31, 2024, and 2023, the following outstanding stock was excluded from the computation of diluted net loss per share as the result was anti-dilutive. SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE 2024 2023 March 31, 2024 2023 (Shares) (Shares) Series C Preferred Stock 3,384,135 3,384,135 Warrants 2,358,101 2,358,101 Total 5,742,236 5,742,236 Anti-dilutive shares 5,742,236 5,742,236 |
SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS | SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS 2024 2023 2023 March 31, December 31, 2024 2023 2023 Period-end GBP£: U.S.$ exchange rate 1.2632 1.2341 1.2199 Weighted average GBP£: U.S.$ exchange rate 1.2684 1.2152 1.2447 |
OTHER RECEIVABLES (Tables)
OTHER RECEIVABLES (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Other Receivables | |
SCHEDULE OF OTHER RECEIVABLES | As of March 31, 2024, and December 31, 2023, accounts receivable consisted of the following: SCHEDULE OF OTHER RECEIVABLES March 31, December 31, 2024 2023 Deposit $ 200 $ 200 UK R&D credit 79,582 80,205 UK VAT receivable 9,155 7,098 Total other receivables $ 88,937 $ 87,503 |
PROPERTY AND EQUIPMENT (Tables)
PROPERTY AND EQUIPMENT (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Property, Plant and Equipment [Abstract] | |
SCHEDULE OF PROPERTY PLANT AND EQUIPMENT | As of March 31, 2024, and December 31, 2023, property and equipment consisted of the following: SCHEDULE OF PROPERTY PLANT AND EQUIPMENT Motor Vehicles Computer Equipment Office Equipment Total Cost At December 31, 2023 $ 53,470 $ 29,646 $ - $ 83,116 Additions - - - - Disposals (53,054 ) (3,502 ) - (56,556 ) Effects of currency translation (416 ) (231 ) - (647 ) At March 31, 2024 - 25,913 - 25,913 Less accumulated depreciation At December 31, 2023 $ 25,997 $ 25,817 $ - $ 51,814 Depreciation expense 1,053 1,449 - 2,502 Disposals (26,847 ) (3,502 ) - (30,349 ) Effects of currency translation (203 ) (200 ) - (403 ) At March 31, 2024 - 23,564 - 23,564 Net book value At March 31, 2024 - 2,349 - 2,349 At December 31, 2023 $ 27,473 $ 3,829 $ - $ 31,302 |
INTANGIBLE ASSETS (Tables)
INTANGIBLE ASSETS (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
SCHEDULE OF TRADEMARKS | As of March 31, 2024, and December 31, 2023, trademarks consisted of the following: SCHEDULE OF TRADEMARKS March 31, December 31, 2024 2023 Trademarks: NewzMine TM $ 13,421 $ 12,994 Citizens Journalist™ 25,367 25,367 Effects of currency translation (2,088 ) (1,804 ) $ 36,700 $ 36,558 |
SCHEDULE OF INTANGIBLE ASSETS | As of March 31, 2024, and December 31, 2023, intangible assets consisted of the following: SCHEDULE OF INTANGIBLE ASSETS Patents Trademarks Intellectual Property Capitalized Acquisition Costs Total Cost At December 31, 2023 $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Cost, beginning $ 220,926 $ 36,558 $ 3,109,540 $ 45,745 $ 3,412,769 Additions 15,139 427 - - 15,566 Effects of currency translation (1,718 ) (285 ) (24,180 ) - (26,183 ) At March 31, 2024 $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Cost, ending $ 234,347 $ 36,700 $ 3,085,360 $ 45,745 $ 3,402,152 Less accumulated amortization At December 31, 2023 $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Less accumulated amortization, beginning $ 8,541 $ - $ 1,940,736 $ 6,864 $ 1,956,141 Amortization expense 1,630 - 49,287 572 51,489 Effects of currency translation (70 ) - (15,089 ) - (15,159 ) At March 31, 2024 $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Less accumulated amortization, ending $ 10,101 $ - $ 1,974,934 $ 7,436 1,992,471 Net book value At March 31, 2024 $ 224,246 $ 36,700 $ 1,110,426 $ 38,309 $ 1,409,681 At December 31, 2023 $ 212,385 $ 36,558 $ 1,168,804 $ 38,881 $ 1,456,628 |
ACCRUED LIABILITIES (Tables)
ACCRUED LIABILITIES (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Payables and Accruals [Abstract] | |
SCHEDULE OF ACCRUED LIABILITIES | As of March 31, 2024, and December 31, 2023, accrued liabilities consisted of the following: SCHEDULE OF ACCRUED LIABILITIES March 31, December 31, 2024 2023 Director fees $ 120,000 $ 90,000 Dividends payable 86,688 65,016 Other accruals 49,892 76,945 Settlement payable 166,986 166,986 Wages and salaries 682,508 544,060 Total Accrued liabilities $ 1,106,074 $ 943,007 |
RELATED PARTY TRANSACTIONS (Tab
RELATED PARTY TRANSACTIONS (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Founder Loan [Member] | |
Short-Term Debt [Line Items] | |
SCHEDULE OF RELATED PARTY TRANSACTION SHARE HOLDERS LOANS | Activity on Loan 1 and Loan 2 arrive at March 31, 2024, and December 31, 2023, balances is as follows: SCHEDULE OF RELATED PARTY TRANSACTION SHARE HOLDERS LOANS Three Months Ended Year Ended 2024 2023 Beginning balance loan 1 current $ 125,910 374,018 Effects of currency translation (980 ) 62,356 Additions 104,930 510,968 Loan resolution agreement – Stephen Morris - (821,432 ) Ending balance – loan 1 current $ 229,575 $ 125,910 Beginning balance loan 2 non-current $ 552,639 $ 525,291 Effects of currency translation (4,298 ) 27,348 Ending balance loan 2 non-current $ 548,341 552,639 Ending balance loan 1 and loan 2 current and non-current $ 777,916 $ 678,549 |
WARRANT LIABILITY (Tables)
WARRANT LIABILITY (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS | For the period ended March 31, 2024, the estimated fair values of the warrant liabilities measured on a recurring basis are as follows : SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS Three Months Ended March 31, 2024 Expected term 1.59 2.50 Expected average volatility 177 220 % Expected dividend yield 8.33 % Risk-free interest rate 1.50 5.46 % |
SUMMARY OF CHANGES IN WARRANT LIABILITIES | The following table summarizes the changes in the warrant liabilities during the three months ended March 31, 2024, and year ended December 31, 2023: SUMMARY OF CHANGES IN WARRANT LIABILITIES Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Warrant liability December 31, 2022 $ 198,479 Addition of new warrants - Change in fair value of warrant liability (159,363 ) Warrant liability as of December 31, 2023 $ 39,116 Addition of new warrants $ - Change in fair value of warrant liability 1,251 Warrant liability as of March 31, 2024 $ 40,367 |
STOCKHOLDERS_ EQUITY (Tables)
STOCKHOLDERS’ EQUITY (Tables) | 3 Months Ended |
Mar. 31, 2024 | |
Equity [Abstract] | |
SUMMARY OF WARRANTS ACTIVITY | A summary of activity during the three-month period ended March 31, 2024, follows: SUMMARY OF WARRANTS ACTIVITY Warrants Outstanding Weighted Average Number of Weighted Average Remaining life Warrants Exercise Price (years) Outstanding, December 31, 2023 2,538,101 $ 0.32 4.27 Granted - - - Exercised - - - Forfeited/canceled - - - Outstanding, March 31, 2024 2,538,101 $ 0.32 3.52 Exercisable Warrants, March 31, 2024 2,538,101 $ 0.32 3.52 |
SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS | The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2024: SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life (in years) Weighted Average Number of Shares Weighted Average 941,599 3.43 $ 0.34 941,599 $ 0.34 472,205 3.44 0.34 472,205 0.34 562,149 3.57 0.35 562,149 0.35 281,074 3.65 0.22 281,074 0.22 281,074 3.74 0.22 281,074 0.22 2,538,101 3.52 $ 0.32 2,538,101 $ 0.32 |
SUMMARY OF STOCK OPTION ACTIVITY | The following table summarizes the stock options activity for the three months ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY Number of Shares Weighted-Average Exercise Price (per share) Outstanding as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Exercised - - Forfeited or expired - - Outstanding at March 31, 2023 14,400,000 $ 0.1560 Exercisable at March 31, 2024 10,788,000 Weighted-average fair value of options granted in the period $ 0.1560 |
SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS | The weighted average fair value of stock options granted is based on the Black-Scholes option pricing model using the following weighted average assumptions. SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS Three Month March 31, 2024 Expected life in years 9.01 Risk-free interest rate 4.20 % Annual forfeiture rate 0 % Volatility 221 % Expected dividend yield 0 % |
SCHEDULE OF NON-VESTED SHARES | The following table summarizes certain information regarding the Company’s non-vested shares as of the three-month period ended March 31, 2024: SCHEDULE OF NON-VESTED SHARES Number of Shares Weighted-Average Non-vested as of December 31, 2023 14,400,000 $ 0.1560 Granted - - Forfeited or expired - - Vested (10,788,000 ) 0.1560 Non-vested as of March 31, 2024 3,612,000 $ 0.1560 |
SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE | The following table summarizes the stock options exercisable for the three-month period ended March 31, 2024: SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE Options Options Outstanding Exercisable Number of shares 14,400,000 10,788,000 Weighted-average contractual life in years 9.01 9.01 Weighted-average exercise price $ 0.1560 $ 0.1614 Intrinsic value $ 0.00 $ 0.00 |
ORGANIZATION, BUSINESS AND LI_2
ORGANIZATION, BUSINESS AND LIQUIDITY (Details Narrative) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Date of incorporation | Oct. 22, 2019 | ||
Comprehensive income net of tax | $ 446,391 | $ 273,478 | |
Accumulated deficit | (16,095,315) | $ (15,612,775) | |
Working capital | $ 1,678,521 | ||
UWRL [Member] | |||
Ownership percentage | 100% |
SCHEDULE OF COMPUTATION OF DILU
SCHEDULE OF COMPUTATION OF DILUTED NET LOSS PER SHARE (Details) - shares | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive shares | 5,742,236 | 5,742,236 |
Series C Preferred Stock [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive shares | 3,384,135 | 3,384,135 |
Warrant [Member] | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Anti-dilutive shares | 2,358,101 | 2,358,101 |
SCHEDULE OF FOREIGN CURRENCY TR
SCHEDULE OF FOREIGN CURRENCY TRANSLATION ADJUSTMENTS (Details) | Mar. 31, 2024 | Dec. 31, 2023 | Mar. 31, 2023 |
Accounting Policies [Abstract] | |||
Period-end GBP£: U.S.$ exchange rate | 1.2632 | 1.2199 | 1.2341 |
Weighted average GBP£: U.S.$ exchange rate | 1.2684 | 1.2447 | 1.2152 |
SIGNIFICANT ACCOUNTING POLICI_4
SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Accounting Policies [Abstract] | |||
Warrant derivative liability | $ 40,367 | $ 39,116 | |
Foreign currency transaction loss | $ 5,210 | $ 19,142 |
SCHEDULE OF OTHER RECEIVABLES (
SCHEDULE OF OTHER RECEIVABLES (Details) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Other Receivables | ||
Deposit | $ 200 | $ 200 |
UK R&D credit | 79,582 | 80,205 |
UK VAT receivable | 9,155 | 7,098 |
Total other receivables | $ 88,937 | $ 87,503 |
SCHEDULE OF PROPERTY PLANT AND
SCHEDULE OF PROPERTY PLANT AND EQUIPMENT (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross, beginning balance | $ 83,116 | ||
Property plant and equipment, additions | |||
Property plant and equipment, Disposals | (56,556) | ||
Effects of currency translation | (647) | ||
Property, plant and equipment, gross balance | 25,913 | ||
Accumulated depreciation, beginning balance | 51,814 | ||
Depreciation expense | 2,502 | $ 3,106 | |
Disposals | (30,349) | ||
Depreciation expense | (403) | ||
Accumulated depreciation, Ending balance | 23,564 | ||
Property, plant and equipment, net | 2,349 | $ 31,302 | |
Vehicles [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross, beginning balance | 53,470 | ||
Property plant and equipment, additions | |||
Property plant and equipment, Disposals | (53,054) | ||
Effects of currency translation | (416) | ||
Property, plant and equipment, gross balance | |||
Accumulated depreciation, beginning balance | 25,997 | ||
Depreciation expense | 1,053 | ||
Disposals | (26,847) | ||
Depreciation expense | (203) | ||
Accumulated depreciation, Ending balance | |||
Computer Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross, beginning balance | 29,646 | ||
Property plant and equipment, additions | |||
Property plant and equipment, Disposals | (3,502) | ||
Effects of currency translation | (231) | ||
Property, plant and equipment, gross balance | 25,913 | ||
Accumulated depreciation, beginning balance | 25,817 | ||
Depreciation expense | 1,449 | ||
Disposals | (3,502) | ||
Depreciation expense | (200) | ||
Accumulated depreciation, Ending balance | 23,564 | ||
Property, plant and equipment, net | 2,349 | 3,829 | |
Office Equipment [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, gross, beginning balance | |||
Property plant and equipment, additions | |||
Property plant and equipment, Disposals | |||
Effects of currency translation | |||
Property, plant and equipment, gross balance | |||
Accumulated depreciation, beginning balance | |||
Depreciation expense | |||
Disposals | |||
Depreciation expense | |||
Accumulated depreciation, Ending balance | |||
Property, plant and equipment, net | |||
Automobiles [Member] | |||
Property, Plant and Equipment [Line Items] | |||
Property, plant and equipment, net | $ 27,473 |
PROPERTY AND EQUIPMENT (Details
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Property, Plant and Equipment [Abstract] | ||
Depreciation expense | $ 2,502 | $ 3,106 |
Loss on disposal of vechicle | $ 9,317 |
SCHEDULE OF TRADEMARKS (Details
SCHEDULE OF TRADEMARKS (Details) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Indefinite-Lived Intangible Assets [Line Items] | ||
Trademarks | $ 36,700 | $ 36,558 |
Effects of currency translation | (2,088) | (1,804) |
Newz Mine [Member] | ||
Indefinite-Lived Intangible Assets [Line Items] | ||
Trademarks | 13,421 | 12,994 |
Citizens Journalist [Member] | ||
Indefinite-Lived Intangible Assets [Line Items] | ||
Trademarks | $ 25,367 | $ 25,367 |
SCHEDULE OF INTANGIBLE ASSETS (
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($) | 3 Months Ended | ||
Mar. 31, 2024 | Mar. 31, 2023 | Dec. 31, 2023 | |
Finite-Lived Intangible Assets [Line Items] | |||
Cost, beginning | $ 3,412,769 | ||
Additions | 15,566 | ||
Effects of currency translation | (26,183) | ||
Cost, ending | 3,402,152 | ||
Less accumulated amortization, beginning | 1,956,141 | ||
Amortization expense | 51,489 | $ 56,521 | |
Effects of currency translation | (15,159) | ||
Less accumulated amortization, ending | 1,992,471 | ||
Net book value | 1,409,681 | $ 1,456,628 | |
Patents [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost, beginning | 220,926 | ||
Additions | 15,139 | ||
Effects of currency translation | (1,718) | ||
Cost, ending | 234,347 | ||
Less accumulated amortization, beginning | 8,541 | ||
Amortization expense | 1,630 | ||
Effects of currency translation | (70) | ||
Less accumulated amortization, ending | 10,101 | ||
Net book value | 224,246 | 212,385 | |
Trademarks [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost, beginning | 36,558 | ||
Additions | 427 | ||
Effects of currency translation | (285) | ||
Cost, ending | 36,700 | ||
Less accumulated amortization, beginning | |||
Amortization expense | |||
Effects of currency translation | |||
Less accumulated amortization, ending | |||
Net book value | 36,700 | 36,558 | |
Intellectual Property [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost, beginning | 3,109,540 | ||
Additions | |||
Effects of currency translation | (24,180) | ||
Cost, ending | 3,085,360 | ||
Less accumulated amortization, beginning | 1,940,736 | ||
Amortization expense | 49,287 | ||
Effects of currency translation | (15,089) | ||
Less accumulated amortization, ending | 1,974,934 | ||
Net book value | 1,110,426 | 1,168,804 | |
Capitalized Acquisition Costs [Member] | |||
Finite-Lived Intangible Assets [Line Items] | |||
Cost, beginning | 45,745 | ||
Additions | |||
Effects of currency translation | |||
Cost, ending | 45,745 | ||
Less accumulated amortization, beginning | 6,864 | ||
Amortization expense | 572 | ||
Effects of currency translation | |||
Less accumulated amortization, ending | 7,436 | ||
Net book value | $ 38,309 | $ 38,881 |
INTANGIBLE ASSETS (Details Narr
INTANGIBLE ASSETS (Details Narrative) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Mar. 31, 2023 | |
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets | $ 15,566 | |
Amortization expenses | 51,489 | $ 56,521 |
Impairment | $ 0 | |
Patents [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets useful lives | 20 years | |
Intangible assets | $ 15,139 | |
Amortization expenses | $ 1,630 | |
Intellectual Property [Member] | ||
Finite-Lived Intangible Assets [Line Items] | ||
Intangible assets useful lives | 7 years | |
Intangible assets | ||
Amortization expenses | $ 49,287 |
SCHEDULE OF ACCRUED LIABILITIES
SCHEDULE OF ACCRUED LIABILITIES (Details) - USD ($) | Mar. 31, 2024 | Dec. 31, 2023 |
Payables and Accruals [Abstract] | ||
Director fees | $ 120,000 | $ 90,000 |
Dividends payable | 86,688 | 65,016 |
Other accruals | 49,892 | 76,945 |
Settlement payable | 166,986 | 166,986 |
Wages and salaries | 682,508 | 544,060 |
Total Accrued liabilities | $ 1,106,074 | $ 943,007 |
LOAN PAYABLE (Details Narrative
LOAN PAYABLE (Details Narrative) - USD ($) | 1 Months Ended | 3 Months Ended | |||
Nov. 30, 2019 | Mar. 31, 2024 | Mar. 31, 2022 | Dec. 31, 2023 | Dec. 31, 2022 | |
Short-Term Debt [Line Items] | |||||
Loan payments | $ 1,691 | $ 2,430 | |||
Nonrelated Party [Member] | |||||
Short-Term Debt [Line Items] | |||||
Loan payable current | $ 12,611 | $ 11,987 | |||
Long term loans payable | $ 0 | $ 12,611 | |||
Vehicle [Member] | |||||
Short-Term Debt [Line Items] | |||||
Debt instrument, term | 5 years | ||||
Interest rate | 6.90% |
SCHEDULE OF RELATED PARTY TRANS
SCHEDULE OF RELATED PARTY TRANSACTION SHARE HOLDERS LOANS (Details) - Founder Loan [Member] - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2024 | Dec. 31, 2023 | |
Short-Term Debt [Line Items] | ||
Beginning balance loan 1 current | $ 125,910 | $ 374,018 |
Effects of currency translation | (980) | 62,356 |
Additions | 104,930 | 510,968 |
Loan resolution agreement – Stephen Morris | (821,432) | |
Ending balance – loan 1 current | 229,575 | 125,910 |
Beginning balance loan 2 non-current | 552,639 | 525,291 |
Effects of currency translation | (4,298) | 27,348 |
Ending balance loan 2 non-current | 548,341 | 552,639 |
Ending balance loan 1 and loan 2 current and non-current | $ 777,916 | $ 678,549 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) | 3 Months Ended | |||||||||||||
Dec. 27, 2023 USD ($) $ / shares shares | Dec. 20, 2022 USD ($) | Dec. 20, 2022 EUR (€) | Sep. 06, 2022 USD ($) | Sep. 06, 2022 EUR (€) | Mar. 31, 2024 USD ($) | Mar. 31, 2022 USD ($) | Mar. 31, 2024 EUR (€) | Dec. 31, 2023 USD ($) | Dec. 31, 2023 EUR (€) | Sep. 08, 2022 USD ($) | Sep. 08, 2022 EUR (€) | Sep. 07, 2022 USD ($) | Sep. 07, 2022 EUR (€) | |
Related Party Transaction [Line Items] | ||||||||||||||
Assignment of advances receivable | $ 1,691 | $ 2,430 | ||||||||||||
Debt instrument face amount | $ 550,468 | € 434,060 | ||||||||||||
Mr. Stephen Morris [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Loan payable obligations | 229,575 | $ 125,910 | ||||||||||||
Promissory notes payable | $ 821,431.87 | |||||||||||||
Common stock, issued | shares | 2,489,186 | |||||||||||||
Conversion price | $ / shares | $ 0.33 | |||||||||||||
Debt instrument face amount | $ 501,049 | € 434,060 | ||||||||||||
Unsecured interest | 0% | 0% | ||||||||||||
Paul Morrissey [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Debt instrument face amount | $ 32,337 | € 25,401 | ||||||||||||
Original issue discount | $ 6,954 | € 5,700 | ||||||||||||
Interest rate | 2.85% | 2.85% | ||||||||||||
Debt instrument outstanding | 34,395 | € 27,229 | 32,337 | € 25,401 | ||||||||||
Second Amendment [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Principal of loan | $ 60,000 | € 52,088 | ||||||||||||
Third Amendment [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Principal of loan | $ 71,540 | € 59,543 | ||||||||||||
Assignment of advances receivable | $ 71,540 | € 59,543 | ||||||||||||
Founder Loan [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Loan payable obligations | $ 1,316,435 | 678,549 | ||||||||||||
Debt instrument call feature | On May 23, 2022, the Company entered an amendment to the Loan Agreement between Bubblr Limited and Mr. Morris to change the loan from a demand loan to have a maturity date on the earlier of (i) the completion of an offering by Bubblr, Inc., in the amount of no less than $7,500,000 in a public offering, or (ii) two years from the date of the amendment. | |||||||||||||
Debt instrument payment terms | In addition, on a date no later than five (5) business days from the completion of bridge financing of no less than $1.5 million USD, the Company shall pay to Mr. Morris an amount equal to £115,000 GBP as an installment payment on the principal of the Loan, and the balance of the principal of the Loan shall be paid at the Maturity Date | |||||||||||||
Bubblr Limited And Morris [Member] | ||||||||||||||
Related Party Transaction [Line Items] | ||||||||||||||
Short term loans payable | $ 552,639 | $ 548,341 |
SCHEDULE OF ESTIMATED FAIR VALU
SCHEDULE OF ESTIMATED FAIR VALUES OF WARRANT LIABILITIES MEASURED ON A RECURRING BASIS (Details) | Mar. 31, 2024 |
Measurement Input, Expected Term [Member] | Minimum [Member] | |
Derivative [Line Items] | |
Expected term | 1 year 7 months 2 days |
Measurement Input, Expected Term [Member] | Maximum [Member] | |
Derivative [Line Items] | |
Expected term | 2 years 6 months |
Measurement Input, Price Volatility [Member] | Minimum [Member] | |
Derivative [Line Items] | |
Warrants and rights outstanding, measurement input | 177 |
Measurement Input, Price Volatility [Member] | Maximum [Member] | |
Derivative [Line Items] | |
Warrants and rights outstanding, measurement input | 220 |
Measurement Input, Expected Dividend Rate [Member] | |
Derivative [Line Items] | |
Warrants and rights outstanding, measurement input | 8.33 |
Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member] | |
Derivative [Line Items] | |
Warrants and rights outstanding, measurement input | 1.50 |
Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member] | |
Derivative [Line Items] | |
Warrants and rights outstanding, measurement input | 5.46 |
SUMMARY OF CHANGES IN WARRANT L
SUMMARY OF CHANGES IN WARRANT LIABILITIES (Details) - Fair Value, Inputs, Level 3 [Member] - USD ($) | 3 Months Ended | 12 Months Ended |
Mar. 31, 2024 | Dec. 31, 2023 | |
Platform Operator, Crypto Asset [Line Items] | ||
Warrant liability, Balance | $ 39,116 | $ 198,479 |
Addition of new warrants | ||
Change in fair value of warrant liability | 1,251 | (159,363) |
Warrant liability, Balance | $ 40,367 | $ 39,116 |
SUMMARY OF WARRANTS ACTIVITY (D
SUMMARY OF WARRANTS ACTIVITY (Details) - $ / shares | 3 Months Ended | 12 Months Ended |
Mar. 31, 2024 | Dec. 31, 2023 | |
Equity [Abstract] | ||
Number of Warrants outstanding Beginning balance | 2,538,101 | |
Weighted Average Exercise Price Outstanding | $ 0.32 | |
Weighted Average Remaining life (years) | 3 years 6 months 7 days | 4 years 3 months 7 days |
Number of Warrants Granted | ||
Weighted Average Exercise Price Granted | ||
Number of Warrants Exercised | ||
Weighted Average Exercise Price Exercised | ||
Number of Warrants Forfeited/canceled | ||
Weighted Average Exercise Price Forfeited/canceled | ||
Number of Warrants outstanding ending balance | 2,538,101 | 2,538,101 |
Weighted Average Exercise Price Outstanding | $ 0.32 | $ 0.32 |
Number of Warrants Exercisable | 2,538,101 | |
Weighted Average Exercise Price Exercisable | $ 0.32 | |
Weighted Average Remaining life (years) Exercisable Warrants | 3 years 6 months 7 days |
SUMMARY OF INFORMATION RELATING
SUMMARY OF INFORMATION RELATING TO OUTSTANDING AND EXERCISABLE WARRANTS (Details) - $ / shares | 3 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | |
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 2,538,101 | 2,538,101 |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 6 months 7 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.32 | $ 0.32 |
Number of Shares, Warrants Exercisable | 2,538,101 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.32 | |
Warrants One [Member] | ||
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 941,599 | |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 5 months 4 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.34 | |
Number of Shares, Warrants Exercisable | 941,599 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.34 | |
Warrants Two [Member] | ||
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 472,205 | |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 5 months 8 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.34 | |
Number of Shares, Warrants Exercisable | 472,205 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.34 | |
Warrants Three [Member] | ||
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 562,149 | |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 6 months 25 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.35 | |
Number of Shares, Warrants Exercisable | 562,149 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.35 | |
Warrants Four [Member] | ||
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 281,074 | |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 7 months 24 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.22 | |
Number of Shares, Warrants Exercisable | 281,074 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.22 | |
Warrants Five [Member] | ||
Class of Warrant or Right [Line Items] | ||
Number of Warrants, Warrants Outstanding | 281,074 | |
Weighted Average Remaining life Contractual life (years), Warrants Outstanding | 3 years 8 months 26 days | |
Weighted Average Exercise Price, Warrants Outstanding | $ 0.22 | |
Number of Shares, Warrants Exercisable | 281,074 | |
Weighted Average Exercise Price, Warrants Exercisable | $ 0.22 |
SUMMARY OF STOCK OPTION ACTIVIT
SUMMARY OF STOCK OPTION ACTIVITY (Details) | 3 Months Ended |
Mar. 31, 2024 $ / shares shares | |
Equity [Abstract] | |
Options Outstanding | shares | 14,400,000 |
Weighted-Average Exercise Price outstanding | $ / shares | $ 0.1560 |
Options Outstanding Grants | shares | |
Weighted-Average Exercise Price Grants | $ / shares | |
Options Outstanding Exercised | shares | |
Weighted-Average Exercise Price Exercised | $ / shares | |
Forfeited or expired | shares | |
Weighted-Average Exercise Price Forfeited or expired | $ / shares | |
Options Outstanding | shares | 14,400,000 |
Weighted-Average Exercise Price outstanding | $ / shares | $ 0.1560 |
Exercisable shares | shares | 10,788,000 |
Weighted average options granted | $ / shares | $ 0.1560 |
SCHEDULE OF THE WEIGHTED AVERAG
SCHEDULE OF THE WEIGHTED AVERAGE FAIR VALUE OF STOCK OPTIONS (Details) | 3 Months Ended |
Mar. 31, 2024 | |
Equity [Abstract] | |
Expected life | 9 years 3 days |
Risk-free interest rate | 4.20% |
Annual forfeiture rate | 0% |
Volatility | 221% |
Expected dividend yield | 0% |
SCHEDULE OF NON-VESTED SHARES (
SCHEDULE OF NON-VESTED SHARES (Details) | 3 Months Ended |
Mar. 31, 2024 $ / shares shares | |
Equity [Abstract] | |
Number of shares | shares | 14,400,000 |
Weighted average | $ / shares | $ 0.1560 |
Number of shares granted | shares | |
Weighted average granted | $ / shares | |
Number of shares forfeited or expired | shares | |
Weighted average forfeited or expired | $ / shares | |
Number of shares vested | shares | (10,788,000) |
Weighted average vested | $ / shares | $ 0.1560 |
Number of shares | shares | 3,612,000 |
Weighted average | $ / shares | $ 0.1560 |
SUMMARY OF STOCK OPTION ACTIV_2
SUMMARY OF STOCK OPTION ACTIVITY OUTSTANDING AND EXERCISABLE (Details) - USD ($) | 3 Months Ended | |
Mar. 31, 2024 | Dec. 31, 2023 | |
Equity [Abstract] | ||
Options outstanding number of shares | 14,400,000 | 14,400,000 |
Options exercisable number of shares | 10,788,000 | |
Options outstanding weighted-average contractual life in years | 9 years 3 days | |
Options exercisable weighted-average contractual life in years | 9 years 3 days | |
Options outstanding weighted-average exercise price | $ 0.1560 | $ 0.1560 |
Options exercisable weighted-average exercise price | $ 0.1614 | |
Options outstanding Intrinsic value | $ 0 | |
Options exercisable Intrinsic value | $ 0 |
STOCKHOLDERS_ EQUITY (Details N
STOCKHOLDERS’ EQUITY (Details Narrative) | 3 Months Ended | |||||||||||
Apr. 01, 2023 | Mar. 04, 2023 USD ($) $ / shares shares | Sep. 24, 2022 USD ($) shares | Sep. 07, 2022 USD ($) shares | May 25, 2022 USD ($) shares | Apr. 24, 2022 USD ($) shares | Mar. 09, 2022 USD ($) shares | Mar. 04, 2022 USD ($) shares | Mar. 31, 2024 USD ($) $ / shares shares | Mar. 31, 2023 USD ($) | Dec. 31, 2023 $ / shares shares | Sep. 07, 2022 EUR (€) | |
Class of Stock [Line Items] | ||||||||||||
Preferred stock, shares authorized | 25,000,000 | |||||||||||
Preferred stock, per share | $ / shares | $ 0.001 | |||||||||||
Warrant shares | 2,538,101 | 2,538,101 | ||||||||||
Debt instrument face amount | $ 550,468 | € 434,060 | ||||||||||
Interest expense | $ | $ 3,592 | $ 1,129 | ||||||||||
Residual loss | $ | 28,043 | |||||||||||
Gain (Loss) on Securitization of Financial Assets | $ | $ 95,768 | |||||||||||
Common stock, shares authorized | 3,000,000,000 | 3,000,000,000 | ||||||||||
Common stock, par value | $ / shares | $ 0.01 | $ 0.01 | ||||||||||
Stock issued during period value | $ | 285,338 | |||||||||||
Dividends value | $ | $ 22,133 | |||||||||||
Common stock, shares issued | 159,690,447 | 159,690,447 | ||||||||||
Common stock, shares outstanding | 159,690,447 | 159,690,447 | ||||||||||
Option vest description | Company granted options for purchasing our Common stock to executives, management, and a non-executive director as consideration for time served. The Board of Directors determine the terms of the stock option grants that are consistent with our 2022 Equity Incentive Plan. | |||||||||||
Option grant description | Our stock option grant general policy is that options vest 40% after 90 days of service, and the remaining options vest monthly over two years. The maximum term is ten years. | |||||||||||
Unrecognized compensation costs | $ | $ 108,990 | |||||||||||
Unrecognized compensation costs | $ | $ 517,783 | |||||||||||
Bubblr Limited And Morris [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Investment company fee waiver terms | 200,000 | |||||||||||
GHS [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Convertible preferred stock value | $ | $ 700,000 | |||||||||||
Preferred stock, share subscriptions | 700 | |||||||||||
Warrant shares | 941,599 | |||||||||||
Gross proceeds | $ | $ 266,000 | |||||||||||
Shares of common stock to Proactive | 281,000 | |||||||||||
Proactive [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Preferred stock, share subscriptions | 160 | |||||||||||
Warrant shares | 472,205 | |||||||||||
Shares of common stock to Proactive | 64,220 | |||||||||||
Proactive Two [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Gross proceeds | $ | $ 290,000 | |||||||||||
GHS Tranche 2 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Warrant shares | 562,149 | |||||||||||
Gross proceeds | $ | $ 184,000 | |||||||||||
GHS Tranche 3 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Gross proceeds | $ | $ 92,000 | |||||||||||
GHS Tranche 4 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Warrant shares | 281,074 | |||||||||||
Gross proceeds | $ | $ 92,000 | |||||||||||
Proactive Total [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Gross proceeds | $ | $ 789,000 | |||||||||||
Warrant Allocated [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Gross proceeds | $ | $ 721,275 | |||||||||||
Consultancy Services [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 625,000 | |||||||||||
Stock issued during period value | $ | $ 100,000 | |||||||||||
Professional Services [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 500,000 | |||||||||||
Stock issued during period value | $ | $ 65,000 | |||||||||||
Investor Relations [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 1,455,784 | |||||||||||
Stock issued during period value | $ | $ 285,338 | |||||||||||
Warrant [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Intrinsic value | $ | $ 0 | |||||||||||
Series C Preferred Stock [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Preferred stock, shares authorized | 2,000 | 2,000 | 2,000 | |||||||||
Preferred stock, per share | $ / shares | $ 1,200 | $ 0.001 | $ 0.001 | |||||||||
Dividend rate | 8% | |||||||||||
Preferred stock conversion basis | Each share of the Series C Convertible Preferred Stock is convertible, at any time and from time to time from and after the issuance at the option of the Holder thereof, into that number of shares of Common Stock (subject to Beneficial Ownership Limitations) determined by dividing the Stated Value of $1,200 of such share by the Conversion Price of $0.3202. | |||||||||||
Preferred stock, liquidation preference value | $ | $ 1,200 | |||||||||||
Conversion Price | $ / shares | $ 0.3202 | |||||||||||
Preferred stock, shares issued | 903 | 903 | ||||||||||
Preferred stock, shares outstanding | 903 | 903 | ||||||||||
Dividends shares | 311,159 | |||||||||||
Dividends value | $ | $ 43,805 | |||||||||||
Series C Preferred Stock [Member] | Redeemed After 90 Days [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Debt instrument, redemption, description | The Company shall have the right to redeem the Series C Convertible Preferred Stock upon three business days of written notice at a price equal to 120% of the Stated Value together with any accrued but unpaid dividends; and | |||||||||||
Series C Preferred Stock [Member] | GHS [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Warrant shares percent | 75% | |||||||||||
Series C Preferred Stock [Member] | Tranche 1 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 300 | |||||||||||
Series C Preferred Stock [Member] | Commitment Shares [Member] | GHS [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 35 | |||||||||||
Series C Preferred Stock [Member] | Commitment Shares [Member] | Proactive [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 8 | |||||||||||
Series C Preferred Stock [Member] | Proactive [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 168 | |||||||||||
Warrant shares percent | 75% | |||||||||||
Series C Preferred Stock [Member] | GHS Tranche 2 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 200 | |||||||||||
Series C Preferred Stock [Member] | GHS Tranche 3 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 100 | |||||||||||
Series C Preferred Stock [Member] | GHS Tranche 4 [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Stock issued during period shares | 100 | |||||||||||
Series C Preferred Stock [Member] | Preferred Stock [Member] | ||||||||||||
Class of Stock [Line Items] | ||||||||||||
Shares of common stock to Proactive | 345,220 | |||||||||||
Interest expense | $ | $ 71,703 |
COMMITMENTS AND CONTINGENCIES (
COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($) | 3 Months Ended | 12 Months Ended | ||||||||
Jul. 06, 2023 | Jul. 01, 2023 | Jun. 15, 2023 | May 12, 2023 | Apr. 06, 2023 | Apr. 01, 2023 | Feb. 14, 2023 | Jan. 31, 2023 | Mar. 31, 2024 | Dec. 31, 2023 | |
Other Commitments [Line Items] | ||||||||||
Non-vested share options | 10,788,000 | |||||||||
Launchpad IR [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Received cash | $ 3,000 | |||||||||
Stephen Morris [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Compensate salary | $ 180,000 | |||||||||
Compensate salary | 60% | |||||||||
Share-Based compensation arrangement description | Company agreed to grant Mr. Morris an option to purchase 3,360,000 shares of common stock at $0.187 per share (628,320) under the 2022 Incentive Plan | |||||||||
Chetwood [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Share-Based compensation arrangement description | Company agreed to grant Mr. Chetwood an option to purchase 3,360,000 shares of common stock at $0.1625 per share ($546,000), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years | |||||||||
Consulting Agreement [Member] | Beyond Media SEZC [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Stock compensation value | $ 7,000 | |||||||||
Shares of common stock | 1,000,000 | |||||||||
Common stock value | $ 180,000 | |||||||||
Separation Agreements [Member] | Rik Willard [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Number of restricted stock | $ 116,000 | $ 79,250 | ||||||||
Amended Employment Agreement [Member] | Maximum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 450,000 | |||||||||
Amended Employment Agreement [Member] | Minimum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 90,000 | |||||||||
Amended Employment Agreement [Member] | Rik Willard [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Settlement amount | $ 112,418 | $ 86,811 | ||||||||
Amended Employment Agreement [Member] | Stephen Morris [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Compensate salary | $ 450,000 | |||||||||
Deferred compensation | $ 5,000,000 | |||||||||
Deferred compensation | $ 270,000 | |||||||||
Amended Employment Agreement [Member] | Chetwood [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Compensate salary | 60% | |||||||||
Deferred compensation | $ 5,000,000 | |||||||||
Deferred compensation | 450,000 | |||||||||
Deferred compensation payment | $ 180,000 | |||||||||
Non-vested share options | 1,092,000 | |||||||||
Amended Employment Agreement [Member] | David Chetwood [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Deferred compensation | 236,200 | |||||||||
Amended Employment Agreement [Member] | David Chetwood [Member] | Maximum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 450,000 | |||||||||
Amended Employment Agreement [Member] | David Chetwood [Member] | Minimum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 180,000 | |||||||||
Amended Employment Agreement [Member] | Burks [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Share-Based compensation arrangement description | Company agreed to grant Mr. Burks an option to purchase 4,800,000 shares of common stock at $0.1353 per share ($649,440), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years | Company entered into an employment agreement with Timothy Burks, Chief Executive Officer, and Director. The Company will compensate Mr. Burks $600,000 per annum base pay with payments reduced by 60% to $240,000 per annum until the Company has secured $5,000,000 in debt or equity financing. | ||||||||
Amended Employment Agreement [Member] | Mr.Burks [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Non-vested share options | 1,800,000 | |||||||||
Amended Employment Agreement [Member] | Timothy Burks [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Deferred compensation | 270,000 | |||||||||
Amended Employment Agreement [Member] | Timothy Burks [Member] | Maximum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 600,000 | |||||||||
Amended Employment Agreement [Member] | Timothy Burks [Member] | Minimum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 240,000 | |||||||||
Non Executive Director Agreement [Member] | Paul Morrissey [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Share-Based compensation arrangement description | Company entered into a Non-executive Director Agreement with Paul Morrissey. The Company will compensate Mr. Morrissey $300,000 per annum directors fee, with payments reduced by 60% to $120,000 per annum until the Company has secured $5,000,000 in debt or equity financing. | |||||||||
Non Executive Director Agreement [Member] | Mr Morrissey [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Share-Based compensation arrangement description | Company agreed to grant Mr. Morrissey an option to purchase 1,920,000 shares of common stock at $0.1353 per share ($259,776), with 40% vesting after 90 days of service and 60% vesting monthly over the following two years | |||||||||
Non-vested share options | 720,000 | |||||||||
Non Executive Director Agreement [Member] | Morrissey [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Deferred compensation | 270,000 | |||||||||
Non Executive Director Agreement [Member] | Morrissey [Member] | Maximum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | 300,000 | |||||||||
Non Executive Director Agreement [Member] | Morrissey [Member] | Minimum [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Annual payment | $ 120,000 | |||||||||
Virtual Office Space [Member] | ||||||||||
Other Commitments [Line Items] | ||||||||||
Monthly rate | $ 200 |